E3 Ubiquitin Ligase NEDD4 Promotes Influenza Virus Infection by Decreasing Levels of the Antiviral Protein IFITM3

PLoS Pathogens

Volumn 11, Issue 8, 2015, Pages

  Chesarino, Nicholas M ^a   McMichael, Temet M ^a   Yount, Jacob S ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON INDUCED MEMBRANE PROTEIN; LEUPEPTIN; MEMBRANE PROTEIN; SMAD PROTEIN; UBIQUITIN PROTEIN LIGASE NEDD4; UNCLASSIFIED DRUG; ESCRT PROTEIN; FRAGILIS PROTEIN, MOUSE; IFITM3 PROTEIN, HUMAN; NEDD4 UBIQUITIN PROTEIN LIGASES; RNA BINDING PROTEIN; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOSOME; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA A; INFLUENZA B; LYSOSOME; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; REGULATORY MECHANISM; UBIQUITINATION; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; GENE SILENCING; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CELL LINE; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOPRECIPITATION; INFLUENZA, HUMAN; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84940773599     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005095     Document Type: Article

References (68)

1. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, et al. (2011) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS pathogens 7: e1001258. doi: 10.1371/journal.ppat.1001258 21253575
2. Yount JS, Moltedo B, Yang YY, Charron G, Moran TM, et al. (2010) Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nature chemical biology 6: 610–614. doi: 10.1038/nchembio.405 20601941
3. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243–1254. doi: 10.1016/j.cell.2009.12.017 20064371
4. Hach JC, McMichael T, Chesarino NM, Yount JS, (2013) Palmitoylation on conserved and non-conserved cysteines of murine IFITM1 regulates its stability and anti-influenza A virus activity. Journal of virology 87: 9923–9927. doi: 10.1128/JVI.00621-13 23804635
5. Perreira JM, Chin CR, Feeley EM, Brass AL, (2013) IFITMs restrict the replication of multiple pathogenic viruses. Journal of molecular biology 425: 4937–4955. doi: 10.1016/j.jmb.2013.09.024 24076421
6. Diamond MS, Farzan M, (2013) The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nature reviews Immunology 13: 46–57. doi: 10.1038/nri3344 23237964
7. Lu J, Pan Q, Rong L, He W, Liu SL, et al. (2011) The IFITM proteins inhibit HIV-1 infection. Journal of virology 85: 2126–2137. doi: 10.1128/JVI.01531-10 21177806
8. Compton AA, Bruel T, Porrot F, Mallet A, Sachse M, et al. (2014) IFITM Proteins Incorporated into HIV-1 Virions Impair Viral Fusion and Spread. Cell host & microbe 16: 736–747.
9. Tartour K, Appourchaux R, Gaillard J, Nguyen XN, Durand S, et al. (2014) IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity. Retrovirology 11: 103. doi: 10.1186/s12977-014-0103-y 25422070
10. Everitt AR, Clare S, Pertel T, John SP, Wash RS, et al. (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484: 519–523. doi: 10.1038/nature10921 22446628
11. Bailey CC, Huang IC, Kam C, Farzan M, (2012) Ifitm3 limits the severity of acute influenza in mice. PLoS pathogens 8: e1002909. doi: 10.1371/journal.ppat.1002909 22969429
12. Wang Z, Zhang A, Wan Y, Liu X, Qiu C, et al. (2013) Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proceedings of the National Academy of Sciences of the United States of America 111.
13. Zhang YH, Zhao Y, Li N, Peng YC, Giannoulatou E, et al. (2013) Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nature Communications 4.
14. Xuan Y, Wang LN, Li W, Zi HR, Guo Y, et al. (2015) IFITM3 rs12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysis. Epidemiology and infection: 1–10.
15. Yount JS, Karssemeijer RA, Hang HC, (2012) S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. The Journal of biological chemistry 287: 19631–19641. doi: 10.1074/jbc.M112.362095 22511783
16. Feeley EM, Sims JS, John SP, Chin CR, Pertel T, et al. (2011) IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry. PLoS pathogens 7: e1002337. doi: 10.1371/journal.ppat.1002337 22046135
17. Melvin WJ, McMichael TM, Chesarino NM, Hach JC, Yount JS, (2015) IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells. Viruses 7: 3035–3052. doi: 10.3390/v7062759 26075508
18. Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, et al. (2013) IFITM Proteins Restrict Viral Membrane Hemifusion. PLoS pathogens 9: e1003124. doi: 10.1371/journal.ppat.1003124 23358889
19. Desai TM, Marin M, Chin CR, Savidis G, Brass AL, et al. (2014) IFITM3 Restricts Influenza A Virus Entry by Blocking the Formation of Fusion Pores following Virus-Endosome Hemifusion. PLoS pathogens 10: e1004048. doi: 10.1371/journal.ppat.1004048 24699674
20. Taubenberger JK, Kash JC, (2010) Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 7: 440–451. doi: 10.1016/j.chom.2010.05.009 20542248
21. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, et al. (2007) The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25: 5086–5096. 17544181
22. Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR, (1984) Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38: 745–755. 6548414
23. Chesarino NM, McMichael TM, Hach JC, Yount JS, (2014) Phosphorylation of the Antiviral Protein IFITM3 Dually Regulates its Endocytosis and Ubiquitination. The Journal of biological chemistry.
24. Chesarino NM, McMichael TM, Yount JS, (2014) Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications. Future microbiology 9: 1151–1163. doi: 10.2217/fmb.14.65 25405885
25. Rotin D, Kumar S, (2009) Physiological functions of the HECT family of ubiquitin ligases. Nature reviews Molecular cell biology 10: 398–409. doi: 10.1038/nrm2690 19436320
26. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, et al. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome biology 10: R130. doi: 10.1186/gb-2009-10-11-r130 19919682
27. Martin-Serrano J, Eastman SW, Chung W, Bieniasz PD, (2005) HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. The Journal of cell biology 168: 89–101. 15623582
28. Chesarino NM, Hach JC, Chen JL, Zaro BW, Rajaram MV, et al. (2014) Chemoproteomics reveals Toll-like receptor fatty acylation. BMC biology 12: 91. doi: 10.1186/s12915-014-0091-3 25371237
29. Malakhova OA, Zhang DE, (2008) ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. The Journal of biological chemistry 283: 8783–8787. doi: 10.1074/jbc.C800030200 18287095
30. Okumura A, Pitha PM, Harty RN, (2008) ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proceedings of the National Academy of Sciences of the United States of America 105: 3974–3979. doi: 10.1073/pnas.0710629105 18305167
31. Pincetic A, Kuang Z, Seo EJ, Leis J, (2010) The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. Journal of virology 84: 4725–4736. doi: 10.1128/JVI.02478-09 20164219
32. Magnifico A, Ettenberg S, Yang C, Mariano J, Tiwari S, et al. (2003) WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. The Journal of biological chemistry 278: 43169–43177. 12907674
33. Liu Q, Zhou H, Langdon WY, Zhang J, (2014) E3 ubiquitin ligase Cbl-b in innate and adaptive immunity. Cell cycle 13: 1875–1884. doi: 10.4161/cc.29213 24875217
34. Scheffner M, Kumar S, (2014) Mammalian HECT ubiquitin-protein ligases: biological and pathophysiological aspects. Biochimica et biophysica acta 1843: 61–74. doi: 10.1016/j.bbamcr.2013.03.024 23545411
35. Jia R, Xu F, Qian J, Yao Y, Miao C, et al. (2014) Identification of an endocytic signal essential for the antiviral action of IFITM3. Cellular Microbiology.
36. Jia R, Pan Q, Ding S, Rong L, Liu SL, et al. (2012) The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. Journal of virology 86: 13697–13707. doi: 10.1128/JVI.01828-12 23055554
37. Zhang Y, Makvandi-Nejad S, Qin L, Zhao Y, Zhang T, et al. (2015) Interferon-induced transmembrane protein-3 rs12252-C is associated with rapid progression of acute HIV-1 infection in Chinese MSM cohort. AIDS 29: 889–894. doi: 10.1097/QAD.0000000000000632 25784441
38. Fouladkou F, Landry T, Kawabe H, Neeb A, Lu C, et al. (2008) The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization. Proceedings of the National Academy of Sciences of the United States of America 105: 8585–8590. doi: 10.1073/pnas.0803233105 18562292
39. Weidner JM, Jiang D, Pan XB, Chang J, Block TM, et al. (2010) Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. Journal of virology 84: 12646–12657. doi: 10.1128/JVI.01328-10 20943977
40. Amini-Bavil-Olyaee S, Choi YJ, Lee JH, Shi M, Huang IC, et al. (2013) The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell host & microbe 13: 452–464.
41. Hoekstra D, Klappe K, de Boer T, Wilschut J, (1985) Characterization of the fusogenic properties of Sendai virus: kinetics of fusion with erythrocyte membranes. Biochemistry 24: 4739–4745. 3000417
42. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, et al. (2007) IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proceedings of the National Academy of Sciences of the United States of America 104: 1371–1376. 17227866
43. Lai C, Struckhoff JJ, Schneider J, Martinez-Sobrido L, Wolff T, et al. (2009) Mice Lacking the ISG15 E1 Enzyme UbE1L Demonstrate Increased Susceptibility to both Mouse-Adapted and Non-Mouse-Adapted Influenza B Virus Infection. Journal of virology 83: 1147–1151. doi: 10.1128/JVI.00105-08 19004958
44. Zhao C, Hsiang TY, Kuo RL, Krug RM, (2010) ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proceedings of the National Academy of Sciences of the United States of America 107: 2253–2258. doi: 10.1073/pnas.0909144107 20133869
45. Tang YJ, Zhong GX, Zhu LH, Liu X, Shan YF, et al. (2010) Herc5 Attenuates Influenza A Virus by Catalyzing ISGylation of Viral NS1 Protein. Journal of immunology 184: 5777–5790.
46. Yuan W, Krug RM, (2001) Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. The EMBO journal 20: 362–371. 11157743
47. Zhao C, Collins MN, Hsiang TY, Krug RM, (2013) Interferon-induced ISG15 pathway: an ongoing virus-host battle. Trends in microbiology 21: 181–186. doi: 10.1016/j.tim.2013.01.005 23414970
48. Versteeg GA, Hale BG, van Boheemen S, Wolff T, Lenschow DJ, et al. (2010) Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein. Journal of virology 84: 5423–5430. doi: 10.1128/JVI.02395-09 20219937
49. Harty RN, Brown ME, Wang GL, Huibregtse J, Hayes FP, (2000) A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: Implications for filovirus budding. Proceedings of the National Academy of Sciences of the United States of America 97: 13871–13876. 11095724
50. Harty RN, Brown ME, McGettigan JP, Wang G, Jayakar HR, et al. (2001) Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. Journal of virology 75: 10623–10629. 11602704
51. Strack B, Calistri A, Accola MA, Palu G, Gottlinger HG, (2000) A role for ubiquitin ligase recruitment in retrovirus release. Proceedings of the National Academy of Sciences of the United States of America 97: 13063–13068. 11087860
52. Fouladkou F, Lu C, Jiang C, Zhou L, She Y, et al. (2010) The ubiquitin ligase Nedd4-1 is required for heart development and is a suppressor of thrombospondin-1. The Journal of biological chemistry 285: 6770–6780. doi: 10.1074/jbc.M109.082347 20026598
53. Cao XR, Lill NL, Boase N, Shi PP, Croucher DR, et al. (2008) Nedd4 controls animal growth by regulating IGF-1 signaling. Science signaling 1: ra5. doi: 10.1126/scisignal.1160940 18812566
54. Guo H, Qiao G, Ying H, Li Z, Zhao Y, et al. (2012) E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity. Cell reports 1: 472–482. 22763434
55. Yang B, Gay DL, MacLeod MK, Cao X, Hala T, et al. (2008) Nedd4 augments the adaptive immune response by promoting ubiquitin-mediated degradation of Cbl-b in activated T cells. Nature Immunology 9: 1356–1363. doi: 10.1038/ni.1670 18931680
56. Xu C, Fan CD, Wang X, (2015) Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase. Oncogene 34: 281–289. doi: 10.1038/onc.2013.557 24413081
57. Kawabe H, Neeb A, Dimova K, Young SM, Jr.Takeda M, et al. (2010) Regulation of Rap2A by the ubiquitin ligase Nedd4-1 controls neurite development. Neuron 65: 358–372. doi: 10.1016/j.neuron.2010.01.007 20159449
58. Nagpal P, Plant PJ, Correa J, Bain A, Takeda M, et al. (2012) The ubiquitin ligase Nedd4-1 participates in denervation-induced skeletal muscle atrophy in mice. PloS one 7: e46427. doi: 10.1371/journal.pone.0046427 23110050
59. Han Z, Lu J, Liu Y, Davis B, Lee MS, et al. (2014) Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses. Journal of virology 88: 7294–7306. doi: 10.1128/JVI.00591-14 24741084
60. Mund T, Lewis MJ, Maslen S, Pelham HR, (2014) Peptide and small molecule inhibitors of HECT-type ubiquitin ligases. Proceedings of the National Academy of Sciences of the United States of America 111: 16736–16741. doi: 10.1073/pnas.1412152111 25385595
61. Gao S, Alarcon C, Sapkota G, Rahman S, Chen PY, et al. (2009) Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. Molecular cell 36: 457–468. doi: 10.1016/j.molcel.2009.09.043 19917253
62. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu HT, et al. (2000) Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Molecular cell 6: 1365–1375. 11163210
63. Milkereit R, Rotin D, (2011) A Role for the Ubiquitin Ligase Nedd4 in Membrane Sorting of LAPTM4 Proteins. PloS one 6.
64. Moltedo B, Li W, Yount JS, Moran TM, (2011) Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection. PLoS pathogens 7: e1002345. doi: 10.1371/journal.ppat.1002345 22072965
65. Strahle L, Marq JB, Brini A, Hausmann S, Kolakofsky D, et al. (2007) Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins. Journal of virology 81: 12227–12237. 17804509
66. Lopez CB, Yount JS, Hermesh T, Moran TM, (2006) Sendai virus infection induces efficient adaptive immunity independently of type I interferons. Journal of virology 80: 4538–4545. 16611914
67. Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, et al. (2009) A versatile viral system for expression and depletion of proteins in mammalian cells. PloS one 4: e6529. doi: 10.1371/journal.pone.0006529 19657394
68. Chutiwitoonchai N, Hiyoshi M, Hiyoshi-Yoshidomi Y, Hashimoto M, Tokunaga K, et al. (2013) Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins. Microbes and infection / Institut Pasteur 15: 280–290. doi: 10.1016/j.micinf.2012.12.003 23376165